The results indicated that 8 pathways were significantly altered in the Ang II-treated LECs (P < 0.05), which included olfactory transduction, thyroid cancer, RIG-I-like receptor signaling pathway, ECM-receptor interaction, alcoholism, the Jak-STAT signaling pathway and galactose metabolism (Figure 5E). The gene discussed is SOAT1; the disease is thyroid cancer.